126 related articles for article (PubMed ID: 35709957)
1. Longitudinal Natural History of Pediatric Subjects Affected with Mucopolysaccharidosis IIIB.
Okur I; Ezgu F; Giugliani R; Muschol N; Koehn A; Amartino H; Harmatz P; de Castro Lopez MJ; Couce ML; Lin SP; Batzios S; Cleary M; Solano M; Peters H; Lee J; Nestrasil I; Shaywitz AJ; Maricich SM; Kuca B; Kovalchin J; Zanelli E
J Pediatr; 2022 Oct; 249():50-58.e2. PubMed ID: 35709957
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
[TBL] [Abstract][Full Text] [Related]
3. Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B.
Whitley CB; Cleary M; Eugen Mengel K; Harmatz P; Shapiro E; Nestrasil I; Haslett P; Whiteman D; Alexanderian D
J Pediatr; 2018 Jun; 197():198-206.e2. PubMed ID: 29661560
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B.
Muschol N; Koehn A; von Cossel K; Okur I; Ezgu F; Harmatz P; de Castro Lopez MJ; Couce ML; Lin SP; Batzios S; Cleary M; Solano M; Nestrasil I; Kaufman B; Shaywitz AJ; Maricich SM; Kuca B; Kovalchin J; Zanelli E
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36413418
[TBL] [Abstract][Full Text] [Related]
5. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
Truxal KV; Fu H; McCarty DM; McNally KA; Kunkler KL; Zumberge NA; Martin L; Aylward SC; Alfano LN; Berry KM; Lowes LP; Corridore M; McKee C; McBride KL; Flanigan KM
Mol Genet Metab; 2016 Nov; 119(3):239-248. PubMed ID: 27590925
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.
Shapiro EG; Nestrasil I; Delaney KA; Rudser K; Kovac V; Nair N; Richard CW; Haslett P; Whitley CB
J Pediatr; 2016 Mar; 170():278-87.e1-4. PubMed ID: 26787381
[TBL] [Abstract][Full Text] [Related]
7. Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB.
Ellinwood NM; Valentine BN; Hess AS; Jens JK; Snella EM; Jamil M; Hostetter SJ; Jeffery ND; Smith JD; Millman ST; Parsons RL; Butt MT; Chandra S; Egeland MT; Assis AB; Nelvagal HR; Cooper JD; Nestrasil I; Mueller BA; Labounek R; Paulson A; Prill H; Liu XY; Zhou H; Lawrence R; Crawford BE; Grover A; Cherala G; Melton AC; Cherukuri A; Vuillemenot BR; Wait JCM; O'Neill CA; Pinkstaff J; Kovalchin J; Zanelli E; McCullagh E
J Pharmacol Exp Ther; 2022 Sep; 382(3):277-286. PubMed ID: 35717448
[TBL] [Abstract][Full Text] [Related]
8. Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB.
Whitley CB; Vijay S; Yao B; Pineda M; Parker GJM; Rojas-Caro S; Zhang X; Dai Y; Cinar A; Bubb G; Patki KC; Escolar ML
Mol Genet Metab; 2019 Feb; 126(2):131-138. PubMed ID: 30635159
[TBL] [Abstract][Full Text] [Related]
9. Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.
Harm TA; Hostetter SJ; Nenninger AS; Valentine BN; Ellinwood NM; Smith JD
Vet Pathol; 2021 Jan; 58(1):205-222. PubMed ID: 33205707
[TBL] [Abstract][Full Text] [Related]
10. Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.
McCarty DM; DiRosario J; Gulaid K; Killedar S; Oosterhof A; van Kuppevelt TH; Martin PT; Fu H
Metab Brain Dis; 2011 Mar; 26(1):9-19. PubMed ID: 21225451
[TBL] [Abstract][Full Text] [Related]
11. Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions.
Egeland MT; Tarczyluk-Wells MM; Asmar MM; Adintori EG; Lawrence R; Snella EM; Jens JK; Crawford BE; Wait JCM; McCullagh E; Pinkstaff J; Cooper JD; Ellinwood NM
Sci Rep; 2020 Nov; 10(1):20365. PubMed ID: 33230178
[TBL] [Abstract][Full Text] [Related]
12. Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
Kan SH; Elsharkawi I; Le SQ; Prill H; Mangini L; Cooper JD; Lawrence R; Sands MS; Crawford BE; Dickson PI
Mol Genet Metab; 2021 Jun; 133(2):185-192. PubMed ID: 33839004
[TBL] [Abstract][Full Text] [Related]
13. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
14. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of biomarkers for Sanfilippo syndrome.
Saville JT; Flanigan KM; Truxal KV; McBride KL; Fuller M
Mol Genet Metab; 2019; 128(1-2):68-74. PubMed ID: 31104888
[TBL] [Abstract][Full Text] [Related]
16. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
[TBL] [Abstract][Full Text] [Related]
17. Sanfilippo syndrome type B: Analysis of patients diagnosed by the MPS Brazil Network.
Montenegro YHA; de Souza CFM; Kubaski F; Trapp FB; Burin MG; Michelin-Tirelli K; Leistner-Segal S; Facchin ACB; Medeiros FS; Giugliani L; Ribeiro EM; Lourenço CM; Cardoso-Dos-Santos AC; Ribeiro MG; Kim CA; Castro MAA; Embiruçu EK; Steiner CE; Moreira MLC; Montano HQ; Baldo G; Giugliani R
Am J Med Genet A; 2022 Mar; 188(3):760-767. PubMed ID: 34806811
[TBL] [Abstract][Full Text] [Related]
18. Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice.
Mohammed EE; Snella EM; Rutz-Mendicino MM; Echevarria FD; Awedikian R; Whitley EM; Ellinwood NM
Mol Genet Metab; 2012 Sep; 107(1-2):129-35. PubMed ID: 22867887
[TBL] [Abstract][Full Text] [Related]
19. Competitive binding of extracellular accumulated heparan sulfate reduces lysosomal storage defects and triggers neuronal differentiation in a model of Mucopolysaccharidosis IIIB.
De Pasquale V; Scerra G; Scarcella M; D'Agostino M; Pavone LM
Biochim Biophys Acta Mol Cell Res; 2021 Oct; 1868(11):119113. PubMed ID: 34329663
[TBL] [Abstract][Full Text] [Related]
20. Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B).
Zafeiriou DI; Savvopoulou-Augoustidou PA; Sewell A; Papadopoulou F; Badouraki M; Vargiami E; Gombakis NP; Katzos GS
Brain Dev; 2001 Oct; 23(6):385-9. PubMed ID: 11578848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
